The Clinical Development Team at Solid Biosciences is responsible for designing and overseeing clinical trials aimed at evaluating the safety and efficacy of treatments for Duchenne muscular dystrophy. This team collaborates closely with regulatory bodies, manages study protocols, and ensures compliance with clinical guidelines, ultimately driving innovative therapies from the lab into patient care.